Roche launches Elecsys HCV Duo immunoassay for hepatitis C virus
Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status.
Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status.
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
Completion of the demerger of Haleon and share consolidation of GSK
George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies
PM congratulates citizens on crossing the 200 crore milestone of Covid vaccination drive
ABDM Hackathon Round 1 – Kickstarting Unified Health Interface (UHI) is being held from 14th to 17th July 2022 as a hybrid event
Manish led SeQuent since 2014 and played a major role in transforming the company
Jublia (Efinaconazole) topical solution, 10% had annual sales of $292 million in the United States according to IQVIA data (IQVIA MAT May 2022).
To strengthen the integrated human-centric preventive health screening ‘Phygital’ ecosystem in India
Subscribe To Our Newsletter & Stay Updated